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Abstract
Background. Cancer is a leading cause of death globally and in Indonesia. Cancer itself and the treatment 
often cause physical and psychological changes that affect patients’ quality of life (QoL). This study aimed 
to determine the level of depression and QoL in cancer patients.
Material and methods. This cross-sectional study involved 94 respondents who had chemotherapy in a 
public hospital in Indonesia. The study was conducted from January to April 2018. The depression level 
was assessed using the Beck Depression Inventory II (BDI II) while patients’ QoL was measured using the 
EORTC QLQ-C30. Data were analysis using Pearson correlation.
Results. The present study found that the mean score of depression was 8.65 ± 6.53, which reflected their 
normal condition. The global QoL for patients with cancer in this study was high. The levels of depression 
and QoL in the study were contrary to previous studies. Fatigue and pain were the top two highest scores 
in the symptom scales. The study indicates moderate negative correlation between global QoL and de-
pression. There is a need to develop intervention and management of patients undergoing chemotherapy 
to maintain patients’ QoL and psychological aspects of care.
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Introduction
Cancer is a global health problem, causing 
9.6 million deaths in 2018 alone [1]. The Internatio-
nal Agency on Cancer Research reports that there 
were 14.1 million new cases, of which 57% occurred 
in less developed countries including parts of Africa 
and Asia [2]. Furthermore, the report also states that 
cancer incidence is particularly high in Indonesia, 
with 299,700 new cases of cancer in Indonesia and 
194,500 cancer-related deaths recorded in 2012. Most 
cancer patients present to health care providers at the 
late stage of the disease [3]. This was supported by 
one study conducted at several Primary Health Care 
Centres in one Indonesian province, which found 
80% of newly diagnosed cancer patients presented 
in advanced stages [4].
The process of cancer and its treatment have im-
pacts on patients that include physical and emotional 
functioning. Studies from western countries reported 
the physical impact of advanced cancer on the indi-
vidual, including the high prevalence of pain [5, 6], 
fatigue, weakness, and appetite loss [7–9]. The reduc-
tion in physical functioning and the burden of multiple 
symptoms due to cancer can result in poorer quality of 
life (QoL) [10]. In terms of psychological functioning, 
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depression is a common comorbidity among cancer 
patients, affecting 10–22% of this population [11, 
12]. Depression and anxiety disorders are frequently 
experienced by advanced cancer patients who are 
receiving palliative care [12, 13]. Nevertheless, a num-
ber of studies have suggested that depression among 
cancer patients in palliative care is under-recognised 
by healthcare professionals [13, 14].
QoL is defined by the World Health Organisation 
as an individual’s perception of life, values, standards, 
and interest in the framework of culture. Symptoms 
experienced by patients with cancer, including physical 
and psychological symptoms, affect their QoL [15]. 
Evaluating QoL and depression is an increasingly im-
portant issue in cancer patients. QoL and depression, 
particularly among cancer patients, is increasingly 
being studied in Indonesia. However, available studies 
focus only on one of those two aspects. No studies 
have yet been published that investigate depressive 
symptoms and QoL among cancer patients in Indo-
nesia. Therefore, the aims of this study were: 1) to 
assess level of depression and health-related QoL of 
cancer patients; and 2) to evaluate the association 
of depressive symptoms and QoL. The current study, 
which investigated depressive symptoms and QoL in 
Indonesia, may serve as a bridge for better cancer 
management in clinical practice.
Patients and methods
This cross-sectional study involved a total of 94 can-
cer patients. The study was conducted in a public hospi-
tal. Ethical approval was provided by the organisation 
(No. 137/EP-FKIK-UMY/II/2018). The study was conducted 
in accordance with the Declaration of Helsinki. Patients 
diagnosed with stage 3 or 4 cancer and undergoing 
chemotherapy, aged 18 years or older, were invited to 
participate in the study. Participants were provided with 
a participant information sheet describing the purpose 
of the study, their right to confidentiality, and their right 
to withdraw at any time without consequence. 
Before completing the questionnaires, partici-
pants were asked to complete a consent form. This 
study utilised three questionnaires: a standardised 
sociodemographic questionnaire, as well as validated 
Indonesian versions of the European Organisation for 
Research and Treatment of Cancer QoL Questionnaire 
(EORTC QLQ-C30) and the Beck Depression Inventory-II 
(BDI-II). The sociodemographic questionnaire sought 
information about the participant’s age, education, 
employment status, religion, and frequency of con-
ducting daily worship. Disease-related information 
was also collected (i.e. stage of cancer, time of dia-
gnosis, and cancer treatment). These questionnaires 
were administered by the researchers during the 
participants’ visit to the oncology unit at the hospital. 
This also provided participants with the opportunity to 
ask any questions of the researchers that they might 
have had about the study.
The EORTC QLQ-C30 was used to measure patients’ 
QoL because this instrument has been confirmed to 
be reliable and valid for cancer populations in mul-
ticultural settings [16, 17]. As the name implies, the 
EORTC QLQ-C30 consists of 30 questions categorised 
into global health status/QoL and two scales: func-
tional scales (i.e. physical, role, emotional, cognitive 
and social functions) and physical symptom scales 
(i.e. fatigue, nausea and vomiting, pain, dyspnoea, 
insomnia, loss of appetite, constipation, and diarrho-
ea). Participant responses are recorded via a modified 
Likert-type scale with anchors 1 (not at all), 2 (a lit-
tle), 3 (quite a bit), and 4 (very much) for each item; 
except for the global health status/QoL scale, which 
has response options ranging from 1 (very poor) to 
7 (excellent). Higher scores represent a better QoL for 
functional scales whereas higher scores in symptom 
scales mean worse QoL.
Depression was measured using the BDI-II, which 
gives a minimum score of 0 and a maximum score of 
63. Total scores are categorised into the following six 
categories: normal (1–10), mild mood disturbance 
(11–16), borderline clinical depression (17–20), mo-
derate depression (21–30), severe depression (31–40), 
and extreme depression (> 40). All the instruments 
were translated into Bahasa Indonesia and reliability 
was tested using Cronbach’s alpha at 0.90 for the 
EORTC QLQ-30 and 0.90 for the BDI-II.
Statistical analysis
Sociodemographic and disease-related informa-
tion were calculated using descriptive statistics. The 
results are presented as percentage and mean ± stan-
dard deviation. The continuous variables were tested 
for normalcy using the Kolmogorov test. The parame-
tric Pearson test was used to test correlation of QOL 
and depression of patients. A 5% level of statistical 
significance was used for variables (P < 0.05). Data 
were analysed using IBM SPSS for windows (version 
23.0; SPSS Inc., Chicago, IL, USA).
Results
The researchers recruited 111 patients, 11 of whom 
declined to participate and six did not complete the 
questionnaires; as a result, 94 patients were included 
in the analysis (the response rate was 84.7%). Table 1 
illustrates the sociodemographic characteristics and 
disease-related information of the participants. The 
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majority of the patients were female (79%), aged 
20–75 years, with a mean age of 44.72 years, not 
working (76%), and were primary school graduates 
(64%). As shown in Table 1, most of the participant 
were Muslim (91%), with the remaining 6% being 
Hindi, Christian, and Catholic. The majority of respon-
dents regularly conducted worship (95%). Most of 
the participants (86%) were diagnosed cancer more 
than three months previoulsy, and all of the partici-
pants underwent chemotherapy. 
The mean values of EORTC QLQ-C30 scores for 
all scales and items are presented in Table 2. The 
study found that the mean scores for global health 
status/QoL tended to be toward the higher end of 
the scale. Similarly, the mean score for cognitive 
functioning was highest, whereas the mean score for 
physical functioning was the lowest, as compared to 
other subscales in the functional scale. Fatigue, pain, 
and insomnia attained the three highest mean scores 
in the symptom scale. As shown in Table 2, the higher 
global QoL and functional scale scores reflect a higher 
QoL, while the higher score in the symptom scales 
reflect a deterioration in the QoL. Table 2 identifies the 
mean score for depression: 8.65 ± 6.531. This score 
is consistent with mild mood disturbance. 
The data presented in Table 3 show that global 
health status, and the scores for most subscales 
in the function and symptom scales (except for 
cognitive subscale and diarrhoea), are significantly 
associated with depression. The higher scores for 
global health status and functioning are correlated 
with the lower scores for depression, whereas the 
higher scores in the symptom scales reflect higher 
levels of depression.
Discussion
In this study the reference data of the quality 
of life and level of depression in cancer patients in 
Indonesia were presented. It was found that the de-
pression level of the patients was considered as mild 
mood disturbance. The majority of respondents in 
this study were women. The findings of this study are 
consistent with those of previous studies. For example, 
a systematic review investigating depression in women 
with breast cancer found that most studies tended to 
show mild levels of depression among women with 
breast cancer [18]. 
The average depression score reflects that patients 
with cancer in the present study are considered nor-
mal. This finding is contrary to previous studies, in 
Indonesia and in other countries, which indicate mild 
to higher levels of depression. For example, a study 
by Widiyono and Setiyarini found that the level of 
depression among cancer patients in two Indone-
sian public hospitals ranged from mild to severe, with 
more than half of the patients reporting moderate to 
severe depression [19]. In addition, a systematic review 
investigating the prevalence of long-term depres-
sion among a sample of 12,499 patients after being 
diagnosed with breast cancer found that depressive 
symptoms ranged from 9.4% to 66.1% [20].
The score of depression in the present study 
was considered normal; this could be influenced 
by several factors, including the length of diagno-
sis and spirituality. The majority of patients in our 
study were diagnosed with cancer more than three 
months previously and probably had been able to 
accept the disease experienced at this time. This is 
Table 1. Demographic characteristics of patients
Demographic cha-
racteristics
f (%) Mean ± SD
Age (Mean ± SD)
(Min–Max)
44.72 ± 11. 302
20–75
Gender
Male
Female
19 (20.2%)
75 (79.8%)
Religion 
Islam
Christian
Catholic
Hindi
86 (91.5%)
2 (2.1%)
1 (1.1%)
5 (5.3%)
Education level
None 
Primary school 
Middle school
Higher education
20 (21.3%)
38 (40.4%)
19 (20.2%)
17 (18.1%)
Employment status
Not working 
Working
76 (80.9%)
18 (19.1%)
Cancer stadium
Stadium III
Stadium IV
78 (83%)
16 (17%)
Type of cancer 
Breast cancer 
Ovarian cancer
Nasopharyngeal 
cancer
Cervix cancer
Colon cancer
Others 
54 (57.4%)
8 (8.5%)
14 (14.9%)
7 (7.4%)
6 (6.4%)
5 (5.4%)
Length of diagnosis
1–3 months
> 3 months
11 (11.7%)
83 (88.3%)
Frequency of religious 
worship 
Always
Often
Sometimes 
Never
91 (96.8%)
2 (2.1%)
1 (1.1%)
0 (0%)
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supported by findings from a study conducted by 
Bai et al., showing that within one to three months 
after being diagnosed with advanced cancer the pa-
tients experienced depression, existential crisis, and 
decreased QoL but returned to normal six months 
after cancer diagnosis [21]. Another factor that we 
might speculate influenced depression in this study 
is spirituality. A study among cancer survivors shows 
that meaning/peace as part of spirituality can protect 
cancer survivors from depression [22]. Although in 
the present study, the respondents had a different 
cancer trajectory, they reported being engaged in 
regular acts of worship. This might suggest that 
patients in this study had surrendered themselves to 
God, which might include trusting in the inevitability 
of their treatment. 
The study indicates a generally positive QoL among 
cancer patients in this study, as supported by the 
scores for global QoL/health status and most sub-
scales in the functional scale, especially in terms of 
cognitive functioning. The scores on the symptoms 
scale, however, particularly for fatigue, pain, insomnia, 
loss of appetite, and financial difficulty, were high. 
The findings of this study support those of previous 
studies. For example, a study among cancer patients 
receiving chemotherapy in a public hospital in Ban-
dung, Indonesia, scored highest for QoL in cognitive 
function, while the highest average scores report by 
cancer patients were for the symptoms of loss of 
appetite and fatigue [23]. Another study in Kuwait 
found that a sample of 45 advanced cancer patients 
reported issues with similar symptoms, such as pain, 
Table 2. Status of quality of life and depression among patients with cancer
Variable Mean ± SD Min–Max
Domain 
QoL Overall QoL and global health 83.59 ±27.229 0–100
Function scale Physical function 
Role function 
Emotional function 
Cognitive function 
Social function
78.87 ± 20.754
79.26 ± 25.363
86.44 ± 15.697
93.97 ± 11.160
85.11 ± 22.596
0–100
0–100
33–100
33–100
0–100
Symptoms scale Fatigue 
Nausea and vomiting
Pain
Dyspnoea
Insomnia
Appetite loss 
Constipation
Diarrhoea
Financial problems 
32.03 ± 19.48
14.50 ± 20.74
29.08 ± 19.19
5.32 ± 13.21
26.95 ± 32.89
24.83 ± 28.89
12.41 ± 23.93
3.55 ± 10.333
26.95 ± 30.24
0–100
0–100
0–100
0–66.7
0–100
0–100
0–100
0–33
0–100
Depression 8.09 ± 5.95 0–30
Table 3. Correlation of quality of life and depression
Depression
QoL Global health status/QoL –0.310 (p : 0.002)*
Function scale Physical
Role 
Emotional
Cognitive
Social
–0.406 (p : 0.000)*
–0.324 (p : 0.001)*
–0.571 (p : 0.000)*
–0.161 (p : 0.121)
–0.403 (p : 0.000)*
Symptoms scale
Financial problem
Total QoL
Fatigue 
Nausea and vomiting 
Pain
Dyspnoea
Insomnia
Appetite loss 
Constipation 
Diarrhoea
0.516 (p : 0.000)*
0.131 (p : 0.210)
0.395 (p : 0.000)*
0.003 (p : 0.003)*
0.463 (p : 0.000)*
0.296 (p : 0.004)*
0.189 (p : 0.067)
0.064 (p : 0.541)
0.462 (p : 0.000)*
0.332 (p : 0.001)*
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fatigue, anorexia, weight loss, and dyspnoea [24]. 
Such symptoms are commonly experienced by cancer 
patients and can be caused either by the disease itself 
or the treatment [25]. 
In addition to physical symptoms, our study also 
found that the burden of financial problems was 
a significant issue for these patients, which is similar 
to the findings of previous studies in Indonesia and 
India [10, 26]. A study comparing symptoms among 
patients with cancer in Indonesia and the Netherlands 
found that patients from Indonesia experienced gre-
ater financial problems [26]. The financial problems 
in the study might reflect the general economic trend 
in Indonesia where approximately 75% of Indone-
sian citizens lack access to health insurance, thus being 
required to pay for healthcare using their own money.
The result of the present study replicates the 
findings of previous studies about the relationship 
between QoL and depression. The study found that 
global health status and most functional were signi-
ficantly correlated with depression, except cognitive 
and diarrhoea. A moderate negative correlation be-
tween global health status, the functional scale, and 
depression was indicated in the study. These findings 
are similar to the previous studies of Mystakidou et al. 
(2013) and Polat et al. (2014), in that individuals with 
higher QoL had lower levels of depression [27, 28].
Nevertheless, several limitations can be identified 
in this study. The cross-sectional design of this study 
predisposes the results to some level of respondent 
bias and the possibility of social acceptability bias. In 
addition, the sample was drawn from a single state, 
with the majority of the sample being female, and 
because the stage of cancer is not homogenous, one 
should be cautious about generalising the findings of 
this study to larger populations. The researcher was 
also present with the patients during data collection; 
as such, the face-to-face nature of data collection 
might introduce another possible source of bias.
Conclusions
The findings of the study demonstrate that cancer 
patients are considered normal in terms of depression, 
and in general they were toward the higher end of 
the scale, which reflected higher QOL. In relation to 
symptoms, similar to cancer patients in other coun-
tries, Indonesian patients with cancer experience pain, 
fatigue, and insomnia. The similarity of these patients’ 
symptoms indicate that symptoms experienced by 
cancer patients are not culturally specific. In summary, 
this study has demonstrated that depression is signi-
ficantly associated with poor health-related QoL in 
terms of symptoms. These findings suggest the need 
to develop specific services aimed at those undergoing 
chemotherapy to target symptom screening, symptom 
management, and to maintain the patient’s QoL and 
psychological well-being. 
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